Imbria Pharmaceuticals
imbria.comImbria is a privately held, clinical stage company developing novel therapies for patients with life-altering cardiometabolic disorders. Our clinical stage pipeline is focused on restoring or improving the cell’s ability to produce energy in cardiovascular disorders where energetic impairment is a fundamental contributor to symptoms and functional deficits. The lead product candidate, Ninerafaxstat, is currently in Phase 2 clinical development in three indications: NHCM, stable angina, and HFpEF. For additional information, please visit www.imbria.com.
Something looks off?Open jobs at Imbria Pharmaceuticals
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.